Page last updated: 2024-12-05

gamma-dodecalactone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Gamma-dodecalactone is a macrocyclic lactone with a sweet, fruity odor. It is a colorless liquid that is soluble in organic solvents but insoluble in water. It is used as a fragrance ingredient in perfumes, cosmetics, and detergents. It is also used as a flavoring agent in foods, such as candy and baked goods. Gamma-dodecalactone is synthesized by a variety of methods, including the reaction of dodecanoic acid with a suitable alcohol, followed by cyclization. It can also be synthesized by fermentation using microorganisms. Gamma-dodecalone is a potent attractant for certain insects, such as moths and beetles, and is used as a lure in insect traps. It has also been shown to have antimicrobial activity. The compound is studied for its potential applications in various fields, such as pharmaceuticals, cosmetics, and food technology. Its unique properties, including its odor, antimicrobial activity, and insect attractant properties, make it an interesting and versatile compound.'
```

gamma-dodecalactone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

gamma-dodecalactone : A gamma-lactone that is oxolan-2-one substituted by an octyl group at position 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID16821
CHEMBL ID195215
CHEBI ID171837
SCHEMBL ID111041
MeSH IDM0507260

Synonyms (85)

Synonym
CHEBI:171837
xi-dihydro-5-octyl-2(3h)-furanone
5-octyloxolan-2-one
5-octyl-tetrahydro-furan-2-one
.gamma. dodecalactone
.gamma.-octyl-.gamma.-butyrolactone
nsc26511
nsc-26511
dodecanoic acid, .gamma.-lactone
dodecanolide-1,4
.gamma.-n-octyl-.gamma.-n-butyrolactone
4-hydroxydodecanoic acid, .gamma.-lactone
gamma-dodecalactone
wln: t5ovtj e8
2(3h)-furanone, dihydro-5-octyl-
2305-05-7
.gamma.-dodecalactone
.gamma.-dodecanolactone
4-dodecanolide
4-hydroxydodecanoic acid lactone
dihydro-5-octylfuran-2(3h)-one
dihydro-5-octyl-2(3h)-furanone
nsc 26511
gamma-n-octyl-gamma-n-butyrolactone
gamma-dodecalactone (natural)
dodecanoic acid, 4-hydroxy-, gamma-lactone
fema no. 2400
einecs 218-971-6
ai3-35986
4-hydroxy-4-octylbutanoic acid lactone
gamma-octyl-gamma-butyrolactone
gamma-dodecanolactone
gamma-dodecalactone, >=97%, fcc, fg
bdbm50168008
5-octyl-dihydro-furan-2-one
CHEMBL195215 ,
gamma-laurolactone
D1576
unii-yx9n4581lu
yx9n4581lu ,
dodecan-4-olide
LMFA07040042
5-octyl-dihydrofuran-2(3h)-one
dtxcid5027190
tox21_302617
NCGC00256822-01
dtxsid7047190 ,
cas-2305-05-7
A816525
5-octyltetrahydrofuran-2-one
AKOS015904896
5-octyldihydrofuran-2(3h)-one
dodecanoic acid, 4-hydroxy-, .gamma.-lactone
gamma-dodecalactone [fcc]
(+/-)-.gamma.-dodecalactone
4-hydroxydodecanoic acid(gamma)-lactone
.gamma.-dodecalactone [fhfi]
gamma dodecalactone
(rs)-.gamma.-dodecalactone
dodecano-1,4-lactone
5-octyltetrahydro-2-furanone
4-hydroxydodecanoic acid gamma.-lactone
.gamma,-octyl-.gamma.-butyrolactone
(gamma)-dodecalactone
(+/-)-4-n-octylbutyrolactone
SCHEMBL111041
(+/-)-delta-dodecanolactone
2-(3h)-furanone, 5-octyldihydro-
(.+/-.)-4-n-octylbutyrolactone
5-octyldihydro-2(3h)-furanone #
.gamma.-dodecanolide
(+/-)-gamma-octyl-gamma-butyrolactone
mfcd00036499
(+/-)-4-dodecanolide
gamma-dodecalactone, analytical standard
AS-61143
gamma-dodecalactone, natural, >=98%, fg
4-(chloromethyl)cinnamicacidmethylester
Q27294762
D89886
CS-0320646
?4-dodecanolide
gamma -dodecanolactone
5-octyl-2-oxolanone
?-dodecalactone
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
fungal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds.
volatile oil componentAny plant metabolite that is found naturally as a component of a volatile oil.
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
gamma-lactoneA lactone having a five-membered lactone ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (14)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency17.68760.006038.004119,952.5996AID1159521; AID1159523
AR proteinHomo sapiens (human)Potency43.21330.000221.22318,912.5098AID1259243; AID1259247; AID1259381; AID743040; AID743042; AID743054
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency29.52730.001022.650876.6163AID1224838; AID1224839; AID1224893
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency37.55000.000214.376460.0339AID720691; AID720692; AID720719
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency26.43700.003041.611522,387.1992AID1159552; AID1159553; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency23.33770.001530.607315,848.9004AID1224841; AID1224849; AID1259401
pregnane X nuclear receptorHomo sapiens (human)Potency30.63790.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency33.02000.000229.305416,493.5996AID1259244; AID1259248; AID743079; AID743080; AID743091
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency0.01740.023723.228263.5986AID743223
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency34.37620.001723.839378.1014AID743083
histone deacetylase 9 isoform 3Homo sapiens (human)Potency28.92400.037617.082361.1927AID1259388
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency34.37620.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency34.37620.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cytochrome P450 1A2Homo sapiens (human)IC50 (µMol)58.00000.00011.774010.0000AID241334
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (24)

Processvia Protein(s)Taxonomy
steroid catabolic processCytochrome P450 1A2Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A2Homo sapiens (human)
cholesterol metabolic processCytochrome P450 1A2Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A2Homo sapiens (human)
toxin biosynthetic processCytochrome P450 1A2Homo sapiens (human)
post-embryonic developmentCytochrome P450 1A2Homo sapiens (human)
alkaloid metabolic processCytochrome P450 1A2Homo sapiens (human)
regulation of gene expressionCytochrome P450 1A2Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 1A2Homo sapiens (human)
dibenzo-p-dioxin metabolic processCytochrome P450 1A2Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
lung developmentCytochrome P450 1A2Homo sapiens (human)
methylationCytochrome P450 1A2Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 1A2Homo sapiens (human)
retinol metabolic processCytochrome P450 1A2Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A2Homo sapiens (human)
cellular respirationCytochrome P450 1A2Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 1A2Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A2Homo sapiens (human)
oxidative demethylationCytochrome P450 1A2Homo sapiens (human)
cellular response to cadmium ionCytochrome P450 1A2Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (14)

Processvia Protein(s)Taxonomy
monooxygenase activityCytochrome P450 1A2Homo sapiens (human)
iron ion bindingCytochrome P450 1A2Homo sapiens (human)
protein bindingCytochrome P450 1A2Homo sapiens (human)
electron transfer activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1A2Homo sapiens (human)
enzyme bindingCytochrome P450 1A2Homo sapiens (human)
heme bindingCytochrome P450 1A2Homo sapiens (human)
demethylase activityCytochrome P450 1A2Homo sapiens (human)
caffeine oxidase activityCytochrome P450 1A2Homo sapiens (human)
aromatase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
endoplasmic reticulum membraneCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID241334Inhibitory concentration against recombinant human cytochrome P450 1A22005Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (13.33)29.6817
2010's10 (66.67)24.3611
2020's3 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.40 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index64.21 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]